| Not Yet Recruiting | A Study Comparing Safety and Efficacy of SHR-3167 Fixed-Dose Titration and Individualized-Dose Titration in Ad Diabetes Mellitus, Type 2 | Phase 2 | 2026-04-01 |
| Not Yet Recruiting | A Trial of Trastuzumab Rezetecan in Unresectable Locally Recurrent/Metastatic Breast Cancer Unresectable Locally Recurrent Breast Cancer, Unresectable Locally Metastatic Breast Cancer | Phase 2 | 2026-04-01 |
| Recruiting | A Clinical Study of HRS-8364 in the Treatment of Advanced Solid Tumor Subjects Solid Tumor | Phase 1 / Phase 2 | 2026-03-19 |
| Recruiting | A Clinical Study on the Safety, Tolerability, Pharmacokinetics and Efficacy of SHR-1049 in Patients With Advan Advanced Solid Tumor | Phase 1 | 2026-03-12 |
| Recruiting | Safety and Efficacy of HRS-9190 Compared to Rocuronium for Bolus Maintenance in Adults Neuromuscular Blockade | Phase 2 | 2026-03-06 |
| Recruiting | A Study of Bupivacaine Liposome Injection in the Treatment of Pain After Thoracoscopic Surgery Local Analgesia Via Nerve Block | Phase 2 | 2026-03-03 |
| Not Yet Recruiting | A Clinical Study Comparing the Relative Bioavailability and Safety of SHR-3167 Injection Diabetes Mellitus | Phase 1 | 2026-03-01 |
| Not Yet Recruiting | Study on the Mass Balance of [14C]HRS-9190 for Injection in Healthy Participants Healthy Adult Male | Phase 1 | 2026-03-01 |
| Not Yet Recruiting | A Clinical Study of SHR-4394 in Combination With Anti-tumor Therapy in Prostate Cancer Prostate Cancer | Phase 1 / Phase 2 | 2026-03-01 |
| Recruiting | A Trial of Tegileridine Fumarate Lnjection for Prolonged Mechanical Ventilation Abirritation in the Intensive Abirritation in the ICU | Phase 2 | 2026-02-24 |
| Recruiting | The Efficacy and Safety of SHR4640 Tablet Combined With 40 mg Febuxostat Tablets in the Treatment of Primary G Primary Gout and Hyperuricemia | Phase 2 | 2026-02-09 |
| Recruiting | A Phase III Study Comparing HRS-4357 With Novel Androgen Receptor Pathway Inhibitors in Patients With Progress PSMA-Positive Progressive Metastatic Castration-Resistant Prostate Cancer | Phase 3 | 2026-02-02 |
| Not Yet Recruiting | Safety and Efficacy of HRS-9190 Compared to Cisatracurium for Continuous Intravenous Infusion in Adults Neuromuscular Blockade | Phase 2 | 2026-02-01 |
| Not Yet Recruiting | A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemoth Patients With Chemotherapy-Induced Thrombocytopenia | Phase 3 | 2026-02-01 |
| Recruiting | A Study of SHR3680, HS-20093 and SHR2554 in Subjects With Prostate Cancer Prostate Cancer | Phase 2 | 2025-12-08 |
| Recruiting | A Phase III Clinical Study of Rezvilutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer Metastatic Hormone-sensitive Prostate Cancer (mHSPC) | Phase 3 | 2025-12-05 |
| Recruiting | A Trial of SHR0302 Tablets and SHR0302 Base Gel in Patients With Non-segmental Vitiligo Non-segmental Vitiligo | Phase 2 | 2025-12-05 |
| Recruiting | A Trial of HRS-4508 Combined With Other Antitumor Therapies in Subjects With Locally Advanced or Metastatic No Lung Cancer | Phase 2 | 2025-12-04 |
| Recruiting | Irinotecan Hydrochloride Liposome Injection (II)in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-l First-line Treatment of Metastatic Pancreatic Cancer | Phase 3 | 2025-12-02 |
| Not Yet Recruiting | HRS 4642 Injection Combined With AG Versus Placebo Combined With AG Therapy in First-Line Advanced or Metastat KRAS G12D-Mutant Advanced or Metastatic Pancreatic Cancer in the First-line Setting | Phase 3 | 2025-12-01 |
| Recruiting | A Phase II Clinical Study of FH-006 for Injection Combined With Other Anticancer Therapies in Subjects With Lu Lung Cancer | Phase 2 | 2025-11-12 |
| Recruiting | Safety, Tolerability and Pharmacokinetic Studies of HRS-2183 for Injection in Healthy Chinese Subjects After S Chinese Healthy Adult Subjects | Phase 1 | 2025-10-30 |
| Completed | Safety and Efficacy of HRS-9190 Compared to Rocuronium for Tracheal Intubation in Adults Neuromuscular Blockade | Phase 2 | 2025-10-30 |
| Recruiting | A Trial of SHR-A1811 Compared to Other Antitumor Therapies as Neoadjuvant Treatments in Early-stage or Locally Early-stage or Locally Advanced HER2-positive Breast Cancer | Phase 3 | 2025-10-23 |
| Recruiting | A Study of HRS-2329 in Participants With Advanced Solid Tumors Harboring RAS Mutations or Amplifications Advanced Solid Tumors Harboring RAS Mutations or Amplifications | Phase 1 | 2025-10-16 |
| Recruiting | A Phase II Trial of SHR-A1811 in HER2-Expressing Recurrent/Metastatic Cervical Cancer Recurrent or Metastatic Cervical Cancer | Phase 2 | 2025-10-11 |
| Recruiting | Phase II Clinical Study of SHR2554 Tablets Combined With Other Anti-tumor Treatments in Non-small Cell Lung Ca Locally Advanced or Metastatic Non-small Cell Lung Cancer | Phase 2 | 2025-10-09 |
| Not Yet Recruiting | A Study of HRS-4508 in Combination With Other Anti-tumor Therapy for Solid Tumor Solid Tumor | Phase 1 / Phase 2 | 2025-10-01 |
| Recruiting | Phase I Study of HRS-6093 in Participants With Advanced Solid Tumors Harboring KRAS G12D Mutations Advanced KRAS G12D Mutant Solid Tumors | Phase 1 | 2025-09-16 |
| Recruiting | A Trial of HRS-4508 in Subjects With Locally Advanced or Metastatic Non-small Cell Lung Cancer Solid Tumor | Phase 2 | 2025-09-12 |
| Recruiting | A Phase I Study of HRS-7172 in Participants With Advanced Solid Tumors Harboring RAS Mutations or Amplificatio Advanced Solid Tumors Harboring RAS Mutations or Amplifications | Phase 1 | 2025-09-12 |
| Recruiting | Safety and Efficacy of SHR2554 Combined With Other Antitumor Therapies in Gastric or Gastro-oesophageal Juncti Advanced Gastric Cancer, Metastatic Gastric Cancer, Gastroesophageal Junction Adenocarcinoma | Phase 2 | 2025-09-05 |
| Completed | A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous Bolus and I Skeletal Muscle Relaxation | Phase 1 | 2025-08-26 |
| Recruiting | A Clinical Study to Evaluate the Pharmacokinetic and Pharmacodynamics Properties of of SHR-3167 in Subjects Wi Type 2 Diabetes | Phase 1 | 2025-08-11 |
| Not Yet Recruiting | A Clinical Study to Evaluate the Safety and Pharmacokinetics of Topical RSS0393 Ointment in Children and Adole Plaque Psoriasis in Children, Plaque Psoriasis in Adolescents | Phase 2 | 2025-08-01 |
| Not Yet Recruiting | A Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors Malignant Solid Tumor | Phase 1 / Phase 2 | 2025-08-01 |
| Active Not Recruiting | A Study Comparing SHR-3167 and Insulin Degludec in Type 2 Diabetic Subjects Treated With Basal Insulin With or Type 2 Diabetes Mellitus | Phase 2 | 2025-07-16 |
| Completed | Effect of HRS-8427 for Injection on the Pharmacokinetics of Furosemide and Metformin in Healthy Subjects。 Health Volunteer | Phase 1 | 2025-07-15 |
| Completed | A Comparative Pharmacokinetic Study of Single-Dose Administration of HR091506 Tablets From Different Batches i Health Volunteer | Phase 1 | 2025-07-10 |
| Recruiting | A Trial of Remimazolam for Intraoperative Sedation in Pediatric and Adolescent Patients Operative Sedation of Pediatric, Operative Sedation of Adolescent Patients | Phase 2 / Phase 3 | 2025-07-10 |
| Recruiting | A Trial of HRS-6213 in Healthy Subjects and Patients With Solid Tumors Patients With Solid Tumors | Phase 1 / Phase 2 | 2025-07-10 |
| Not Yet Recruiting | Phase I/II Clinical Study of HRS-1738 for the Diagnosis of Prostate Cancer Patients PET Imaging in Patients With Prostate Cancer | Phase 1 / Phase 2 | 2025-07-01 |
| Completed | Pharmacokinetics Impact of HRS-8427 on Bupropion and Midazolam in Healthy Subjects Health Volunteer | Phase 1 | 2025-06-23 |
| Completed | A Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Oral HRS-5041 in Healthy Subjects Prostate Cancer | Phase 1 | 2025-06-20 |
| Completed | A Study on the Bioequivalence of Bupivacaine Liposome Injection in Humans Postoperative Local Analgesia | Phase 1 | 2025-06-09 |
| Not Yet Recruiting | A Study of Linperlisib (YY-20394) in Combination With Rituximab in Patients With Relapsed/Refractory Indolent Relapsed/Refractory Indolent NHL | Phase 1 / Phase 2 | 2025-06-01 |
| Recruiting | A Clinical Study of HRS-6209 Combined With Other Treatment Regimens in Patients With Breast Cancer Breast Cancer | Phase 1 / Phase 2 | 2025-05-22 |
| Completed | Study on the Mass Balance of [14C]HRS-8427 for Injection in Healthy Chinese Subjects Healthy Cninese Adult Male | Phase 1 | 2025-05-21 |
| Completed | A Trial of SHR7280 in Healthy Subjects Endometriosis, Uterine Fibroids, Assisted Reproduction | Phase 1 | 2025-05-19 |
| Completed | A Phase 1 Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, Endometriosis, Uterine Fibroids, Assisted Reproduction | Phase 1 | 2025-04-28 |
| Recruiting | A Trial of HRS-6768 in Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 / Phase 2 | 2025-04-24 |
| Completed | A Study to Evaluate the Safety, Tolerability and Dose-Response Relationship of HRS-9190 in Healthy Subjects Skeletal Muscle Relaxation | Phase 1 | 2025-04-23 |
| Recruiting | A Trial of HRS-8427 in the Treatment of Adults With Bacterial Pneumonia Hospital-acquired Bacterial Pneumonia (HABP), Ventilator-associated Bacterial Pneumonia (VABP) | Phase 2 | 2025-04-03 |
| Not Yet Recruiting | A Study of SHR-9803 for Injection in Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 / Phase 2 | 2025-04-01 |
| Not Yet Recruiting | To Evaluate the Efficacy and Safety of RSS0393 Ointment in Patients With Plaque Psoriasis Phase II Study Psoriatic Subjects | Phase 2 | 2025-04-01 |
| Active Not Recruiting | Study of SHR-1209 Administered by Single-site or Multiple-site Subcutaneous Injections in Healthy Volunteers Hypercholesterolemia and Hyperlipidemia | Phase 1 | 2025-03-14 |
| Recruiting | A Study of SHR-A1811 in Subjects With Ovarian Cancer Ovarian Cancer | Phase 3 | 2025-03-13 |
| Recruiting | Investigation of Drug-drug Interaction of Ritonavir and Itraconazole on the Pharmacokinetics of SHR-A1811 in S Advanced Breast Cancer | Phase 1 | 2025-02-17 |
| Active Not Recruiting | A Trial of SHR0302Base in Patients With Vitiligo Vitiligo | Phase 2 | 2025-02-13 |
| Recruiting | A Study of SHR-4394 Injection in Subjects With Prostate Cancer Prostate Cancer | Phase 1 | 2025-01-22 |
| Recruiting | Study of RSS0343 Tablets in Patients With Non-cystic Fibrosis Bronchiectasis Adolescent Asthma | Phase 2 | 2025-01-22 |
| Active Not Recruiting | Efficacy and Safety of SHR-3167 and Insulin Glargine in Type 2 Diabetes Subjects Type 2 Diabetes | Phase 2 | 2025-01-08 |
| Recruiting | Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors Malignant Solid Tumor | Phase 1 / Phase 2 | 2024-12-23 |
| Recruiting | A Study for the Treatment of Metastatic Prostate Cancer With HRS-1167 Tablets Combined With Abiraterone Acetat Prostate Cancer | Phase 1 / Phase 2 | 2024-12-11 |
| Not Yet Recruiting | A Study for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Brain and/or Spin For Contrast-enhanced Magnetic Resonance Imaging (MRI) of Central Nervous System (CNS) Lesions | Phase 2 | 2024-12-01 |
| Recruiting | A Study to Evaluate the Efficacy and Safety of HRG2010 in Parkinson's Disease With Motor Fluctuations Parkinson's Disease | Phase 3 | 2024-11-06 |
| Active Not Recruiting | The Experiment of Noiiglutide Injection in Type 2 Diabetes Patients Type 2 Diabetes | Phase 3 | 2024-10-25 |
| Not Yet Recruiting | A Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Initial Efficacy of HRS-4508 Monotherapy i Advanced Solid Tumors | Phase 1 | 2024-09-30 |
| Recruiting | A Trial of HRS-8427 in the Treatment of Adults With Complicated Urinary Tract Infection, Including Acute Pyelo Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP) | Phase 3 | 2024-09-25 |
| Recruiting | A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate Cancer Prostate Cancer | Phase 1 / Phase 2 | 2024-09-25 |
| Recruiting | A Trial of HRS-6209 in Combination With Fulvestrant, Letrozole, HRS-8080, or HRS-1358 in Breast Cancer Patient Advanced Unresectable or Metastatic Breast Cancer | Phase 1 / Phase 2 | 2024-08-12 |
| Recruiting | A Study of HRS-4642 in Combination With Antineoplastic Agents in Advanced Solid Tumors Advanced Solid Tumors | Phase 1 / Phase 2 | 2024-08-09 |
| Not Yet Recruiting | SHR-4602 for Injection in Subjects With HER2-expressing or -Mutated Unresectable or Metastatic Solid Tumors HER2-expressing or -Mutated Unresectable or Metastatic Solid Tumors | Phase 2 | 2024-08-01 |
| Recruiting | The Phase III Clinical Study of Herombopag for the Treatment of Thrombocytopenia in Chronic Liver Disease Pati Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Surgery | Phase 3 | 2024-07-31 |
| Recruiting | A Study of SHR-A1811 in First-line Treatment of Patients With Advanced or Metastatic Non-small Cell Lung Cance Non-Small Cell Lung Cancer With HER2- Mutations | Phase 3 | 2024-07-29 |
| Active Not Recruiting | A Study of HRS-4642 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation Advanced KRAS G12D Mutant Solid Tumors | Phase 1 / Phase 2 | 2024-07-05 |
| Completed | A Randomized, Double-blind, Placebo-controlled Phase I Clinical Trial to Evaluate the Safety and Pharmacokinet Preoperative Sedation of Adults | Phase 1 | 2024-06-19 |
| Completed | A Study to Evaluate the Mass Balance of [14C]SHR7280 in Healthy Adult Volunteers Assisted Reproduction | Phase 1 | 2024-06-07 |
| Recruiting | Phase II Clinical Study of SHR-A1811 in Patients With HER2 Expression / Amplification of Locally Advanced Unre HER2 Expression / Amplification in Patients With Biliary Tract Cancer | Phase 2 | 2024-06-04 |
| Not Yet Recruiting | Clinical Trial of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults Gout With Hyperuricemia in Adults | Phase 3 | 2024-06-01 |
| Recruiting | A Study of Bupivacaine Liposome Injection in Local Analgesia of Pediatric Patients Local Analgesia Via Infiltration | Phase 4 | 2024-05-21 |
| Completed | A Trial Comparing HR17031 With Insulin Glargine in Patients With Type 2 Diabetes Adult Patients With Type 2 Diabetes | Phase 3 | 2024-05-08 |
| Recruiting | Comparison of HR011408 and NovoRapid® in Subjects With Diabetics Diabetes | Phase 1 | 2024-05-01 |
| Completed | A Study Comparing HR17031 With Insulin Glargine in Patients With Type 2 Diabetes Adult Patients With Type 2 Diabetes Uncontrolled on Oral Antidiabetic Drugs | Phase 3 | 2024-04-30 |
| Completed | Phase I Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RSS0343 Tablets Health Volunteer | Phase 1 | 2024-04-07 |
| Not Yet Recruiting | A Phase II Study of SHR2554 in Patients With Relapsed or Refractory Follicular Lymphoma Follicular Lymphoma | Phase 2 | 2024-04-01 |
| Unknown | Study of the Food Effects of Herombopag Olamine Tablets in Healthy Subjects. Adult Patients With Chronic Primary ITP, Adult Patients With SAA Who do Not Respond Well to Immunosuppressive Therapy | Phase 1 | 2024-04-01 |
| Unknown | A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Ca Recurrent Ovarian Cancer | Phase 1 / Phase 2 | 2024-03-15 |
| Completed | A Study of Remimazolam Tosilate for Sedation in the ICU Sedation in the ICU | Phase 3 | 2024-03-12 |
| Active Not Recruiting | Randomized, Double-blind, Placebo-controlled Study of RSS0393 Ointment in Healthy and Psoriatic Subjects Healthy, Psoriatic Subjects | Phase 1 | 2024-03-01 |
| Recruiting | Gallium (68Ga) Edotreotide PET/CT for Imaging Patients With Gastrointestinal Pancreatic Neuroendocrine Tumors Advanced Gastroenteropancreatic Neuroendocrine Tumor | Phase 3 | 2024-02-22 |
| Recruiting | SHR2554 Clinical Study of Chidamide in the Treatment of T-cell Lymphoma Relapsed/Refractory PTCLT With at Least One Line of Prior Systemic Therapy | Phase 3 | 2024-02-05 |
| Withdrawn | A Trial of HHPG-19K Injection and Auto-HHPG-19K Injection in Prevention of Chemotherapy-related Moderate to Se Patients With Nonmyeloid Malignancies Receiving Antineoplastic Therapy Based on Chemotherapy Regimens at Moderate to High Febrile Neutropenia (FN) Risk | Phase 3 | 2024-02-01 |
| Completed | A SHR0302 BA Study on Healthy Subjects Autoimmune Diseases | Phase 1 | 2024-01-16 |
| Terminated | A Study to Assess the Efficacy and Safety of HRG2005 Inhalation in Patients With Moderate to Severe Chronic Ob Chronic Obstructive Pulmonary Disease | Phase 2 | 2024-01-15 |
| Completed | Effect of Rifampicin on the Pharmacokinetics of HRS-1167 in Healthy Subjects Advanced Solid Tumor | Phase 1 | 2024-01-14 |
| Recruiting | SHR-A1811 for Subjects With Her2-positive Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Pr HER2-positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma | Phase 3 | 2024-01-09 |
| Completed | PK Effects of SHR4640 on Repaglinide and Midazolam, and the Impact of SHR4640 on QT Interval Gout and Hyperuricemia | Phase 1 | 2024-01-04 |
| Unknown | A Study of Remimazolam Tosilate for Sedation in Non-intubated Diagnostic and Therapeutic Procedures Sedation in Non-intubated Diagnostic and Therapeutic Procedures | Phase 4 | 2024-01-01 |
| Completed | Relative Bioavailability Study of HR19042 in Healthy Subjects Primary IgA Nephropathy; Autoimmune Hepatitis | Phase 1 | 2023-12-27 |
| Completed | Assessment of Gastric Emptying by SHR20004 in Healthy Subjects Type 2 Diabetes Mellitus | Phase 1 | 2023-12-26 |
| Recruiting | A Study of SHR2554 With Chemotherapy in Treatment-naïve Patients With Peripheral T-cell Lymphoma Peripheral T-cell Lymphoma | Phase 1 / Phase 2 | 2023-12-22 |
| Completed | Clinical Study of HR091506 Tablets in Treatment of Gout With Hyperuricemia in Adults Gout With Hyperuricemia in Adults | Phase 3 | 2023-12-14 |
| Completed | Bioequivalence Study of 2 Sizes of SHR4640 Tablets Orally in Healthy Subjects Hyperuricemia | Phase 1 | 2023-12-13 |
| Completed | A Study of Remimazolam Tosilate for Sedation in the Upper Gastrointestinal Endoscopy Sedation in the Upper Gastrointestinal Endoscopy | Phase 4 | 2023-12-11 |
| Unknown | A Trial of Intravenous HRS-8427 in the Treatment of Adults With Complicate Urinary Tract Infection, Including Patients With Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP) | Phase 2 | 2023-12-01 |
| Recruiting | A Phase III, Active-Controlled Study of SHR-A1811 Versus Trastuzumab Emtansine (T-DM1) in HER2-Positive Primar HER2-Positive Primary Breast Cancer Participants With Residual Invasive Disease Following Neoadjuvant Therapy | Phase 3 | 2023-11-20 |
| Completed | A Clinical Study to Compare the Bioavailability of HR17031 in Healthy Subjects at Different Sites Type 2 Diabetes | Phase 1 | 2023-11-07 |
| Completed | Effect of Omeprazole on Pharmacokinetics of SHR2554 in Healthy Subjects Malignant Tumor | Phase 1 | 2023-11-06 |
| Active Not Recruiting | A Phase III Study of SHR-A1811 Injection With or Without Pertuzumab in HER2-Positive Recurrent or Metastatic B HER2-PositiveRecurrent or Metastatic Breast Cancer | Phase 3 | 2023-10-16 |
| Completed | A Study to Evaluate the Mass Balance of [14C]SHR2554 in Healthy Adult Volunteers Lymphoma | Phase 1 | 2023-10-07 |
| Not Yet Recruiting | Dalpiciclib Isethionate Tablets Combined With Abiraterone Acetate Tablets (I) and Prednisone Tablets (AA-P) Ve High-volume, Metastatic, Hormone-sensitive Prostate Cancer (mHSPC) | Phase 1 | 2023-10-01 |
| Unknown | Phase I Clinical Study of HRS-9815 for PET/CT Imaging in Patients With Prostate Cancer Prostate Cancer | Phase 1 | 2023-10-01 |
| Unknown | Study of the Food Effects of Herombopag Olamine Tablets in Healthy Subjects Adult Patients With Chronic Primary ITP, Adult Patients With SAA Who do Not Respond Well to Immunosuppressive Therapy | Phase 1 | 2023-10-01 |
| Unknown | A Trial of HRF2105 Patch in Relieving Pain of Osteoarthritis Analgesia and Anti-inflammatory of Osteoarthritis | Phase 2 | 2023-10-01 |
| Unknown | Phase 1/2 Clinical Study of HRS-4357 in Patients With Advanced Prostate Cancer Advanced Prostate Cancer | Phase 1 / Phase 2 | 2023-09-30 |
| Withdrawn | Phase I Study of HRS-7053 Injection in the Treatment of Patients With Advanced Malignancies Advanced Malignant Cancer | Phase 1 | 2023-09-01 |
| Unknown | A Trial of SP2086 With Hepatic Insufficiency Diabetes | Phase 1 | 2023-09-01 |
| Completed | To Compare the Efficacy and Safety of Oral SHR 7280 Tablets With Ganirelix Acetate Injection in Infertile Fema Infertile Female Subjects Undergoing Controlled Ovarian Hyperstimulation to Suppress Premature LH Surge and Prevent Early Ovulation | Phase 3 | 2023-08-29 |
| Active Not Recruiting | A Phase II/III Study of HR070803 in Combination With Oxaliplatin, 5-fluorouracil, Calcium Folinate and Bevaciz Colorectal Cancer | Phase 2 / Phase 3 | 2023-08-14 |
| Recruiting | A Trial of SHR-A1811 Combined With Other Antitumor Therapies in Advanced Solid Tumors. HER2-expressing Advanced Solid Tumors | Phase 1 / Phase 2 | 2023-08-11 |
| Completed | Pharmacokinetic/Pharmacokinetic and Safety Studies of SHR4640 in Subjects With Moderate Renal Insufficiency an Hyperuricemia | Phase 1 | 2023-08-07 |
| Recruiting | Study of HRS-5041 in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC) Advanced Prostate Cancer | Phase 1 | 2023-08-03 |
| Recruiting | A Study of SHR-A1811 in Subjects With Gynaecologic Oncology Gynaecological Malignancies | Phase 2 | 2023-07-10 |
| Recruiting | An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointest Advanced Gastroenteropancreatic Neuroendocrine Tumor | Phase 3 | 2023-07-06 |
| Terminated | A SHR-1210 BE Study on Healthy Subjects Advanced Tumors | Phase 1 | 2023-07-04 |
| Recruiting | SHR-A1811 Versus Investigator's Chemotherapy in Recurrent/Metastatic Breast Cancer Clinical Trial Breast Cancer | Phase 3 | 2023-06-30 |
| Completed | A Study of Remimazolam Tosilate for Prolonged Sedation in the ICU Sedation in the ICU | Phase 1 / Phase 2 | 2023-06-27 |
| Recruiting | HR070803 in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Advanced Pancreatic Ca First-line Treatment of Advanced Pancreatic Cancer | Phase 3 | 2023-06-13 |
| Unknown | A Phase 1 Trial to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-3167 Single I T2DM | Phase 1 | 2023-06-09 |
| Completed | To Assess SHR0302 Oral Solutions and Tablets in Healthy Subjects Clinical Studies of Relative Bioavailability Graft-versus-host Disease | Phase 1 | 2023-05-29 |
| Completed | A Clinical Study Evaluating the Relative Bioavailability of SHR7280 Dry Suspension and Tablets Endometriosis, Uterine Fibroids, Male Hormone-sensitive Prostate Cancer, Assisted Reproduction | Phase 1 | 2023-05-23 |
| Completed | To Compare the Pharmacokinetics and Pharmacodynamics of HR20014, INS068 and INS062 After Single Subcutaneous I Diabetes | Phase 1 | 2023-05-23 |
| Completed | Pharmacokinetics,Pharmacodynamics,Efficacy and Safety of HRG2010 in Parkinson's Disease Patients With Motor Fl Parkinson's Disease | Phase 2 | 2023-05-16 |
| Unknown | Safety and Effectiveness of Trappa Ethanolamine Tablets Combined With Ciclosporin in the Treatment of Primary Non-severe Aplastic Anemia | Phase 2 | 2023-04-26 |
| Unknown | A SHR3680 QT/QTc Study on Castration-Resistant Prostate Cancer Subjects Castration-Resistant Prostate Cancer | Phase 1 | 2023-04-26 |
| Active Not Recruiting | Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Solid Tumors. Chemotherapy-Induced Thrombocytopenia | Phase 3 | 2023-04-25 |
| Completed | Pharmacokinetics and Safety of HRS-8427 in Healthy Volunteers and in Patients With Impaired Renal Function Gram-negative Bacterial Infections | Phase 1 | 2023-04-19 |
| Unknown | A Phase Ⅰb/Ⅱ Clinical Study of SHR-A1811 Combined With Other Therapies in Patients With HER2 Low Advanced or M HER2 Low Advanced or Metastatic Breast Cancer | Phase 1 / Phase 2 | 2023-04-01 |
| Completed | To Compare the Efficacy and Safety of INS068 and Insulin Glargine in Subjects With Type 2 Diabetes Mellitus No Type 2 Diabetes | Phase 3 | 2023-03-31 |
| Completed | To Compare the Efficacy and Safety of INS068 and Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Tr Type 2 Diabetes Mellitus | Phase 3 | 2023-03-31 |
| Active Not Recruiting | A Phase I Clinical Study of the Safety， Tolerability，Pharmacokinetics, and Initial Efficacy of HRS-6209 Monoth Advanced Solid Tumors | Phase 1 | 2023-03-23 |
| Completed | The Pharmacokinetics and Pharmacodynamics Between HR011408 and NovoRapid® in Healthy Subject Diabetes | Phase 1 | 2023-03-20 |
| Completed | Effect of Fluconazole on Pharmacokinetics of SHR2554 in Healthy Subjects Malignant Tumor | Phase 1 | 2023-02-28 |
| Unknown | Extension Study of Herombopag for Pediatric Patients With Chronic Immune Thrombocytopenia Immune Thrombocytopenia | Phase 3 | 2023-01-23 |
| Unknown | Bioequivalence Study of INS062 and Pharmacokinetics and Pharmacokinetics Study of Single Injection of HR20014 Diabetes | Phase 1 | 2023-01-05 |
| Completed | A Study to Evaluate the Pharmacodynamic, Efficacy and Safety of SHR-1703 in Asthma Patients With Eosinophil Ph Asthma With Eosinophilic Phenotype | Phase 2 | 2022-12-22 |
| Unknown | Study of SHR6390 in Renal Insufficiency and Healthy Subjects Breast Cancer | Phase 1 | 2022-12-18 |
| Completed | Pharmacokinetic Test of High-fat Diet After Oral Administration of SHR2554 in Healthy Subjects Malignant Tumor | Phase 1 | 2022-11-15 |
| Completed | A Trial of DDI Between SHR1459 and Efavirenz With Healthy Subjects B-cell Tumors | Phase 1 | 2022-11-04 |
| Completed | A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Autoimmune Hepatitis. Autoimmune Hepatitis | Phase 2 | 2022-10-06 |
| Active Not Recruiting | Phase I Study of HRS-4642 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation Advanced KRAS G12D Mutant Solid Tumors | Phase 1 | 2022-09-21 |
| Completed | A Pharmacokinetic Study of SHR8554 Injection in the Population With Renal Insufficiency and Healthy Participan Moderate to Severe Postoperative Pain | Phase 1 | 2022-09-20 |
| Unknown | Clinical Study of SHR4640 Tablets Combined With Febuxostat Tablets in the Treatment of Primary Gout and Hyperu Primary Gout and Hyperuricemia | Phase 2 | 2022-09-15 |
| Unknown | A Trial of Injectable SHR-A1811 in Combination With Pyrotinib or SHR-1316 in Subjects With Advanced Non-small Advanced Non-small Cell Lung Cancer | Phase 1 / Phase 2 | 2022-09-15 |
| Recruiting | A Phase II/III Study of Efficacy and Safety of SHR7280 Tablets in Subjects With Menorrhagia With Uterine Fibro Uterine Fibroids With Menorrhagia | Phase 2 / Phase 3 | 2022-09-10 |
| Unknown | A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurre Non-small Cell Lung Cancer | Phase 3 | 2022-09-08 |
| Completed | A Study to Evaluate Camrelizumab Plus Rivoceranib (Apatinib) Versus Camrelizumab as Adjuvant Therapy in Patien Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or Ablation | Phase 2 | 2022-09-01 |
| Unknown | Single Dose Study To Study The Absorption, Metabolism And Excretion Of Famitinib Healthy Subjects | Phase 1 | 2022-08-26 |
| Recruiting | Study of HRS-1167 as Monotherapy in Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2022-08-23 |
| Completed | A Non-intervention Fiberoptic Bronchoscopy Study of Remazolam Toluene Sulfonate for Injection Under General An General Anesthesia and Bronchoscopy Sedation | — | 2022-08-18 |
| Unknown | A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Non-Radiographic Axial Spondyloarthrit Non-radiographic Axial Spondyloarthritis | Phase 3 | 2022-08-16 |
| Unknown | A Trial of Camrelizumab for Injection in Combination With Famitinib Malate Capsule and Paclitaxel For Injectio Advanced Solid Tumors | Phase 2 | 2022-08-12 |
| Terminated | A Study to Evaluate the Efficacy and Safety of HR18042 Tablets for Postoperative Analgesia After Impacted Teet Pain | Phase 2 | 2022-08-11 |
| Active Not Recruiting | A Study of TACE Combined With Camrelizumab Plus Rivoceranib (Apatinib) in Patients With Incurable Hepatocellul Hepatocellular Carcinoma | Phase 3 | 2022-08-09 |
| Terminated | A Trial of SHR0410 Injection in Postsurgical Pain Management Postsurgical Pain | Phase 2 | 2022-08-09 |
| Active Not Recruiting | A Trial of SHR-A1811versus Pyrotinib in Combination With Capecitabine in HER2-Positive, Unresectable and/or Me HER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated With Trastuzumab and Taxane | Phase 3 | 2022-08-04 |
| Unknown | A Clinical Study of the Combination of SHR8554 Injection and SHR0410 Injection for the Treatment of Pain After Pain | Phase 2 | 2022-08-01 |
| Unknown | A Phase II Study of HR070803 in the Treatment of Advanced Esophageal Cancer Advanced Esophageal Cancer | Phase 2 | 2022-07-27 |
| Completed | A Pharmacokinetic Study to Evaluate the Drug Interaction Between SHR0302 and CYP Substrates in Healthy Volunte Rheumatoid Arthritis | Phase 1 | 2022-07-15 |
| Unknown | A Trial Comparing the Efficacy and Safety of HR17031 Injection to INS068 Injection and to SHR20004 Injection i Type 2 Diabetes | Phase 2 | 2022-07-08 |
| Completed | A Study of Food Effect on the Pharmacokinetics of Fuzuloparib Capsules in Chinese Healthy Adult Subjects Solid Tumor | Phase 1 | 2022-07-03 |
| Unknown | A Trial of SHR0410 Injection for the Treatment of Pain After Laparoscopic Surgery Postoperative Pain Of Laparoscopic Surgery | Phase 3 | 2022-07-01 |
| Completed | Study on the Pharmacokinetic Effect of Itraconazole on SHR0302 Tablets in Healthy Subjects Rheumatoid Arthritis | Phase 1 | 2022-06-25 |
| Unknown | Phase I Study of HRS-3738 in Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma Recurrent and Refractory Non-Hodgkin's Lymphoma and Multiple Myeloma | Phase 1 | 2022-06-17 |
| Unknown | Study to Evaluate the Mass Balance and Biotransformation of [14C]SHR1459 in Healthy Adult Male Volunteers Healthy Adult Male Volunteers | Phase 1 | 2022-06-07 |
| Recruiting | A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADV Advanced Solid Tumors | Phase 1 / Phase 2 | 2022-05-30 |
| Completed | Study of Bioavailability, Pharmacodynamics and Safety of SHR-1209 Administered by Single Subcutaneous Injectio Hypercholesterolemia and Hyperlipidemia | Phase 1 | 2022-05-25 |
| Unknown | A Phase Ib/II Study of SHR-A1811 Injection in Breast Cancer Breast Cancer | Phase 2 | 2022-05-23 |
| Completed | The Relative Bioavailability of INS068 Injection With Two Different Formulations in Healthy Subjects Diabetes Mellitus | Phase 1 | 2022-05-12 |
| Completed | A Study of HRS7415 Tablets in Patients With Advanced Malignant Tumors Advanced Malignant Tumor | Phase 1 | 2022-05-12 |
| Completed | A Study of SHR8554 Injection for the Treatment of Pain After Orthopedic Surgery Pain | Phase 2 / Phase 3 | 2022-05-11 |
| Completed | Bioequivalence Study of Famitinib Malate in Healthy Volunteers Under Fasting Condition Solid Tumor | Phase 1 | 2022-05-11 |
| Unknown | A Trial of HR091506 Tablets in Treatment of Primary Gout With Hyperuricemia in Adults Primary Gout With Hyperuricemia in Adults | Phase 1 | 2022-04-30 |
| Completed | A Pharmacokinetic Study to Evaluate the Drug Interaction Between HRS5091 and Probe Drugs in Healthy Volunteers Chronic Hepatitis B | Phase 1 | 2022-04-29 |
| Terminated | A Study of SHR-1802 in Patients With Advanced Solid Tumor Advanced Solid Tumor | Phase 2 | 2022-04-22 |
| Withdrawn | A Clinical Study of Hetrombopag Olamine Tablets in Adults Receiving 21-day Cycles of Chemotherapy for Solid Tu Chemotherapy-Induced Thrombocytopenia | Phase 3 | 2022-04-15 |
| Unknown | A Trial of HR17031 Injection With Renal Insufficiency Improved Glycemic Control in Patients With Type 2 Diabetes | Phase 1 | 2022-03-31 |
| Completed | Drug-drug Interaction Study Between Fluconazole and Famitinib in Healthy Subjects Tumor | Phase 1 | 2022-03-14 |
| Completed | Effect of Montmorillonite Power or Loperamide on the Pharmacokinetics of Pyrotinib in Healthy Subjects HER2-positive Recurrent / Metastatic Breast Cancer | Phase 1 | 2022-03-08 |
| Completed | Identify Effective Doses of SHR7280 Tablets in Controlled Ovarian Hyperstimulation (COH) for Female Subjects U Female Subjects Undergoing COH in ART to Prevent Early Ovulation | Phase 2 | 2022-03-06 |
| Completed | A Non-interventional Study of Remazolam Methyl Benzene Sulfonic Acid for Injection in Real-world Clinical Prac Gastroscopic and Colonoscopic Sedation | — | 2022-01-30 |
| Completed | A Study to Evaluate the Efficacy and Safety of HRS4800 Tablets for Postoperative Analgesia After Impacted Teet Pain | Phase 2 | 2022-01-14 |
| Terminated | A Study to Evaluate Camrelizumab Combined With Famitinib as Subsequent Therapy in Patients With Advanced NSCLC Advanced NSCLC | Phase 3 | 2022-01-06 |
| Completed | A Study to Evaluate the Effect of Itraconazole on Pharmacokinetics (PK) of SHR8554 in Healthy Adult Subjects Healthy | Phase 1 | 2022-01-04 |
| Completed | Effect of Omeprazole on the Pharmacokinetics of SHR6390 in Healthy Subjects Advanced Solid Tumor | Phase 1 | 2021-12-27 |
| Unknown | A Trial of HR17031 Injection With Hepatic Insufficiency Improved Glycemic Control in Patients With Type 2 Diabetes | Phase 1 | 2021-12-20 |
| Unknown | A Relative Bioavailability Study of Different Processes of SHR2554 Tablets in Healthy Adult Subjects Lymphoma | Phase 1 | 2021-12-17 |
| Unknown | A Drug-drug Interaction Study of SHR2150 on Healthy Chinese Volunteers Human Immunodeficiency Virus Infection | Phase 1 | 2021-12-13 |
| Unknown | Clinical Study of Retagliptin Phosphate Combined With Metformin in the Treatment of Type 2 Diabetes Type 2 Diabetes | Phase 3 | 2021-12-06 |
| Unknown | A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HR011408 at Two Formulations in Healthy S Diabetes in Adults | Phase 1 | 2021-11-29 |
| Completed | Safety and Pharmacokinetics of Fluzoparib in Healthy Subjects and Those With Impaired Kidney Function Renal Impairment | Phase 1 | 2021-11-09 |
| Terminated | A Trial of SHR3680 in Prostate Cancer Patients Who Are Candidates for Radical Prostatectomy Patients With High-risk Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy | Phase 3 | 2021-11-01 |
| Terminated | A Study of SHR6390 Combined With Famitinib in the Treatment of ER + / HER2- Advanced Breast Cancer ER+ / HER2- Advanced Breast Cancer | Phase 1 | 2021-10-25 |
| Terminated | A Phase I Study of HRS2300 or Combined With SHR-1316 or SHR-1701 or Trametinib or Almonertinib in Patients Wit Advanced Malignancies | Phase 1 | 2021-10-25 |
| Unknown | A Trial of SHR-1703 in Asthma Asthma | Phase 1 | 2021-10-12 |
| Unknown | SHR1459 in Combination With YY-20394 in Recurrent and Refractory B-cell Non-Hodgkin's Lymphoma Recurrent and Refractory B-cell Non-Hodgkin's Lymphoma | Phase 2 | 2021-10-01 |
| Terminated | A Study of Camrelizumab Combined With Rivoceranib Mesylate Versus Investigator's Choice of Regimen in Treatmen Advanced Hepatocellular Carcinoma (HCC) | Phase 3 | 2021-09-26 |
| Completed | A Phase 1 Dose Escalation and Expansion Study Of SHR7280 In Subjects With Hormone Sensitive Prostate Cancer Hormone Sensitive Prostate Cancer | Phase 1 | 2021-09-24 |
| Completed | Pharmacokinetics Study of Famitinib Malate Capsules in Healthy Subjects Solid Tumor | Phase 1 | 2021-09-23 |
| Unknown | A Study to Evaluate the Efficacy and Safety of SHR8008 vs. Fluconazole in Subjects With Recurrent Vulvovaginal Recurrent Vulvovaginal Candidiasis | Phase 3 | 2021-09-14 |
| Completed | Relative Bioavailability Study of HRG2010 in Healthy Subjects Parkinson's Disease | Phase 1 | 2021-09-10 |
| Completed | A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Primary IgA Nephropathy. IgA Nephropathy | Phase 2 | 2021-09-09 |
| Completed | A Study of Human Substance Balance and Biotransformation of [14C]SHR0302 Rheumatoid Arthritis (RA) | Phase 1 | 2021-09-07 |
| Completed | A Drug-drug Interaction Study of Famitinib Malate With a Proton Pump Inhibitor in Healthy Adult Subjects Tumor | Phase 1 | 2021-09-07 |
| Completed | Pharmacokinetics of HR17031 Injection in Healthy Subjects Type 2 Diabetes Mellitus | Phase 1 | 2021-09-02 |
| Unknown | SHR-1701 in Combination With Famitinib in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma | Phase 1 / Phase 2 | 2021-09-01 |
| Completed | A Drug-drug Interaction Study of SHR6390 on Healthy Chinese Volunteers Advanced Solid Tumor | Phase 1 | 2021-09-01 |
| Unknown | To Evaluate the Efficacy and Safety of SHR0302 Tablet in Subjects of Active Psoriatic Arthritis Psoriatic Arthritis | Phase 3 | 2021-08-30 |
| Unknown | A Phase 1, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, Pharmacoki Pain | Phase 1 | 2021-08-23 |
| Unknown | Safety, Tolerability and Pharmacokinetics of the New Formulation SHR-1316 in Subjects With Advanced Tumors Tumor | Phase 1 | 2021-08-10 |
| Completed | Efficacy and Safety of SHR-1209 Combined With Lipid-lowering Agents in Patients With Hypercholesterolemia Non-familial Hypercholesterolemia, Mixed Hyperlipidemia | Phase 3 | 2021-07-30 |
| Active Not Recruiting | Camrelizumab Combined With Famitinib Malate for Treatment of Recurrent/Metastatic Cervical Cancer Cervical Cancer | Phase 3 | 2021-07-23 |
| Completed | A Trial of SHR3162 Combined With Apatinib Mesylate Tablets or SHR3162 Monotherapy in Patients With Metastatic Metastatic Castration Resistant Prostate Cancer | Phase 2 | 2021-07-19 |
| Completed | To Evaluate the Safety and Tolerability of Combined Administration of SHR2285 Tablets With Aspirin, Clopidogre Thrombosis | Phase 1 | 2021-07-13 |
| Completed | A Trial of HR19042 Capsule in Healthy Chinese Subjects Primary IgA Nephropathy | Phase 1 | 2021-07-01 |
| Completed | Drug Interaction Between SHR4640 Tablets and Furosemide Tablets in Healthy Volunteers (Single Center, Single A Healthy Male Subjects | Phase 1 | 2021-06-28 |
| Completed | A Drug-drug Interaction Study Of Fluzoparib (SHR3162) on Patients With Recurrent Ovarian Cancer Recurrent Ovarian Cancer | Phase 1 | 2021-06-25 |
| Completed | A Bioequivalence Study of Hetrombopag in Healthy Subjects Sever Aplastic Anaemia | Phase 1 | 2021-06-25 |
| Completed | A Multicentre, Randomized, Double-blind, Allopurinol Controlled Study to Evaluate the Efficacy and Safety of S Gout | Phase 3 | 2021-06-15 |
| Completed | Pharmacokinetics, Safety and Efficacy of HR020602 Injection in Children Undergoing General Anesthesia Used to Induce and Implement General Anesthesia in Combination With Sedative Anesthetics (Such as Propofol) | Phase 2 | 2021-06-07 |
| Unknown | A Trial of SHR-1701 in Combination With and Without Famitinib Malate in Patients With Extensive Stage Small Ce Lung Cancer | Phase 2 | 2021-05-31 |
| Completed | A Trial of SHR0410 Injection for the Treatment of Pain After Endoscopic Surgery of the Lower Abdominal Pain | Phase 3 | 2021-05-13 |
| Completed | A Trial of Efficacy and Safety of Remimazolam Tosilate for Injection in Local Anesthesia Assisted Sedation Local Anesthesia Assisted Sedation | Phase 2 | 2021-05-07 |
| Unknown | SHR-1701 in Patients With Recurrent/Metastatic Scchn Squamous Cell Carcinoma of Head and Neck | Phase 2 | 2021-05-07 |
| Unknown | A Trial to Evaluate the Safety and PK Profile of HRS4800 in Healthy Subjects Pain | Phase 1 | 2021-05-03 |
| Active Not Recruiting | Phase III Study ：SHR6390/Placebo Combined With Endocrine Therapy for the Adjuvant Treatment of Hormone Recepto Hormone Receptor Positive,Human Epidermal Receptor 2 Negative, Node-positive, High Risk, Early Stage，Female Breast Cancer | Phase 3 | 2021-04-30 |
| Unknown | Efficacy 、Safety and PK of SHR-1314 in Patients With Moderate-to-Severe Plaque Psoriasis Moderate-to-Severe Plaque Psoriasis | Phase 3 | 2021-04-25 |
| Unknown | A Study to Evaluate the Efficacy and Safety of SHR8008 vs. Fluconazole in Subjects With Acute Vulvovaginal Can Acute Vulvovaginal Candidiasis | Phase 3 | 2021-04-24 |
| Active Not Recruiting | A Study of SHR-A1811 in Subjects With Advanced Non-small Cell Lung Cancer Advanced Non-small Cell Lung Cancer | Phase 1 / Phase 2 | 2021-04-23 |
| Completed | Study of SHR-1209 in the Treatment of Hypercholesterolemia and Hyperlipidemia Ⅲ Stage Primary Hypercholesterolemia, Mixed Hyperlipemia | Phase 3 | 2021-04-23 |
| Completed | Comparative Study of Abiraterone Acetate Tablets (I) or ZYTIGA® in Patients With Metastatic Castration-resista Metastatic Castration-resistant Prostate Cancer (mCRPC) | Phase 2 | 2021-04-23 |
| Unknown | A Clinical Study of SHR8554 Injection for the Treatment of Pain After Orthopedic Surgery Pain | Phase 2 / Phase 3 | 2021-04-18 |
| Completed | Effect of Fluconazole on the Pharmacokinetics of Pyrotinib in Healthy Subjects Healthy Subjects | Phase 1 | 2021-04-16 |
| Completed | SHR - 1209 Treatment Efficacy and Safety of the Patients With Hypercholesterolemia Ⅲ Period Clinical Research Primary Hypercholesterolemia | Phase 3 | 2021-04-14 |
| Completed | HR021618 in Moderate to Severe Pain After Abdominal Surgery Pain After Abdominal Surgery | Phase 2 | 2021-04-12 |
| Terminated | A Phase 1 Dose Escalation and Expansion Study Of SHR-1916 In Subjects With Locally Advanced Or Metastatic Soli Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 2021-04-08 |
| Completed | A Study of Irinotecan Liposome in Advanced Pancreatic Cancer Advanced Pancreatic Cancer | Phase 1 | 2021-04-08 |
| Completed | A Study of SHR-1210± SHR-1020 Versus Chemotherapy in Patients With Recurrent or Metastatic Cervical Cancer Recurrent or Metastatic Cervical Cancer | Phase 2 | 2021-04-05 |
| Active Not Recruiting | A Study to Evaluate Camrelizumab Plus Rivoceranib (Apatinib) as Adjuvant Therapy in Patients With Hepatocellul Hepatocellular Carcinoma (HCC) | Phase 3 | 2021-04-01 |
| Completed | A Phase 1 Study of SHR-A1811 in Patients With Selected HER2 Expressing Tumors Gastric Cancer, Colorectal Cancer | Phase 1 | 2021-03-30 |
| Completed | Hetrombopag for Pediatric Patients With Chronic Immune Thrombocytopenia Immune Thrombocytopenia | Phase 3 | 2021-03-29 |
| Unknown | The Effect of SHR20004（Noiiglutide ） on Body Weight in Obese Subjects Without Diabetes Obesity | Phase 2 | 2021-03-29 |
| Completed | A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics ，Pharmacodynamics of Oral SHR2150 in He HIV-1 Infection | Phase 1 | 2021-03-22 |
| Active Not Recruiting | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study of Fuzuloparib Combined With Abira Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Phase 3 | 2021-03-18 |
| Unknown | Multi-dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Renal Anemia | Phase 1 | 2021-03-17 |
| Unknown | A Trial of SHR-1701 in Combination With Famitinib in Patients With Advanced Solid Tumors Solid Tumor | Phase 1 / Phase 2 | 2021-03-17 |
| Completed | Study on the Bioavailability of SHR0302 in Healthy Subjects Healthy Subjects | Phase 1 | 2021-03-15 |
| Completed | Efficacy and Safety of SHR8028 Eye Drops for the Treatment of Dry Eye Disease Dry Eye Disease | Phase 3 | 2021-03-04 |
| Completed | A Clinical Study of SHR8554 Injection for the Treatment of Pain After Abdominal Surgery. Pain | Phase 3 | 2021-03-03 |
| Completed | Safety and Pharmacokinetics of Fluzoparib in Healthy Subjects and Those With Impaired Liver Function Hepatic Impairment, Healthy Subjects | Phase 1 | 2021-03-01 |
| Completed | Effect of SHR8058 on Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction Treatment of Dry Eye Disease With Meibomian Gland Dysfunction | Phase 3 | 2021-02-04 |
| Completed | A Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral Antidiabetic Type 2 Diabetes | Phase 2 | 2021-02-04 |
| Unknown | An Investigational Study of SHR3680 in Participants With Mild to Moderate Liver Impairment and Healthy Partici Hepatic Impairment, Healthy Participants | Phase 1 | 2021-02-03 |
| Terminated | A Study to Evaluate SHR-1210 in Combination With Famitinib Plus Chemotherapy in Subjects With NSCLC. Non-squamous Non-small-cell Lung Cancer | Phase 3 | 2021-02-01 |
| Unknown | The Study is Being Conducted to Evaluate the Efficacy and Safety of SHR-1316 in Combination With Chemo-radioth Small-cell Lung Cancer | Phase 3 | 2021-01-22 |
| Withdrawn | A Trial of SHR-1701 With or Without Famitinib in Patients With Advanced or Metastatic NSCLC Non-Small-Cell Lung Cancer | Phase 2 | 2021-01-15 |
| Unknown | Relative Bioavailability Study of SHR3680 Healthy Male Subjects | Phase 1 | 2021-01-06 |
| Unknown | Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy Diabetes Mellitus, Type II | Phase 3 | 2021-01-01 |
| Unknown | A Trial of HR021618 in Postsurgical Pain Management Postsurgical Pain Management | Phase 2 | 2020-12-17 |
| Unknown | A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Resectable Pancreatic Cancer Pancreatic Cancer | Phase 1 | 2020-12-17 |
| Completed | Study to Investigate Relative Bioavailability of Different Formulations of SHR6390 in Healthy Subjects Healthy Volunteers | Phase 1 | 2020-12-13 |
| Completed | A Study of Camrelizumab Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy in Participants Triple Negative Breast Cancer | Phase 3 | 2020-12-09 |
| Completed | A Study to Evaluate the Efficacy and Safety of HR18042 Tablets in the Treatment of Postoperative Pain of Impac Moderate to Severe Acute Pain | Phase 2 | 2020-12-08 |
| Unknown | A Study of SHR3680 in Combination With Docetaxel in the Treatment of mCRPC Prostate Cancer Metastatic | Phase 2 | 2020-12-02 |
| Unknown | An Investigational Study of SHR6390 in Participants With Mild to Moderate Liver Impairment and Healthy Partici Hepatic Impairment, Healthy Participants | Phase 1 | 2020-12-01 |
| Unknown | Study on the Food Effects of Oral SHR4640 Tablets in Healthy Volunteers Healthy Subjects | Phase 1 | 2020-12-01 |
| Completed | A Trial of SHR-1701 in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Pancreatic Cancer Pancreatic Cancer | Phase 1 / Phase 2 | 2020-11-24 |
| Completed | Drug-Drug Interaction of SHR1459 With a Strong CYP3A Index Inducer (Rifampicin) Healthy Subjects, Drug-drug Interaction, Pharmacokinetics, SHR1459 | Phase 1 | 2020-11-24 |
| Unknown | Drug-durg Interaction of SHR3680 With Digoxin, Rosuvastatin Calcium and Metformin Hydrochloride Drug-drug Interaction,SHR3680 | Phase 1 | 2020-11-19 |
| Unknown | Multi-dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Anemia Associated Chronic Kidney Disease | Phase 1 | 2020-11-17 |
| Completed | A Pharmacokinetic Interaction Study Between Apatinib Mesylate and Repaglinide or Bupropion in Advanced Solid T Advanced Solid Tumor | Phase 1 | 2020-11-16 |
| Unknown | Drug-Drug Interaction of Pyrotinib With a Moderate CYP3A Inducer Healthy Subjects, Drug-drug Interaction, Pyrotinib | Phase 1 | 2020-11-12 |
| Completed | Study to Evaluate the Mass Babance and Biotransformation of [14C]SHR6390 in Healthy Adult Male Volunteers Healthy Adult Male Volunteers | Phase 1 | 2020-11-11 |
| Unknown | A Trial of SHR-1701 With or Without Chemotherapy in Patients With Stage III NSCLC Non-Small-Cell Lung Cancer | Phase 2 | 2020-11-10 |
| Withdrawn | A Trial of SHR1258 in Patients With Biliary Tract Cancer Biliary Tract Cancer | Phase 2 | 2020-11-01 |
| Completed | A Phase 2 Trial of Fluzoparib Combined With Apatinib Versus Fluzoparib Monotherapy in Treatment With Relapsed Relapsed Ovarian Cancer | Phase 2 | 2020-10-16 |
| Completed | A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Ankylosing Spondylitis Ankylosing Spondylitis | Phase 2 / Phase 3 | 2020-10-14 |
| Unknown | Study on the Bioavailability of Three Different Prescription Processes of SHR4640 Tablets in Healthy Volunteer Primary Gout, Hyperuricemia | Phase 1 | 2020-10-01 |
| Unknown | A Trial of HR18034 in Inguinal Hernia Repair Inguinal Hernia Repair | Phase 1 | 2020-10-01 |
| Completed | A Trial of Hetrombopag in Healthy and Hepatic Impairment Subjects Sever Aplastic Anaemia | Phase 1 | 2020-09-28 |
| Recruiting | Study to Evaluate the Efficacy and Safety of Camrelizumab and Apatinib in Patients With GC/GEJC Gastric Cancer | Phase 3 | 2020-09-21 |
| Completed | Relative Bioavailability of Early Phase and Late Phase Hetrombopag Olamine Formulations Bioavailability Study | Phase 1 | 2020-09-18 |
| Terminated | Efficacy and Safety of Famitinib Versus Sunitinib in the Treatment of Advanced Gastrointestinal Stromal Tumour Gastrointestinal Stromal Tumors | Phase 3 | 2020-09-12 |
| Completed | Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon Non-squamous NSCLC, HER2 Exon 20 Mutation | Phase 3 | 2020-09-11 |
| Completed | The PK/PD Study of SHR7280 Tablets in Healthy Subjects. Healthy Subjects | Phase 1 | 2020-09-11 |
| Completed | A Safety and Efficacy Study of SHR-1702 Monotherapy in Patients With Acute Myeloid Leukemia (AML) or Myelodysp AML, MDS | Phase 1 | 2020-09-10 |
| Completed | A Study of SHR-A1811 in Subjects With Advanced Malignant Solid Tumors Advanced Solid Tumors | Phase 1 | 2020-09-07 |
| Completed | Effect of Hetrombopag on the Pharmacokinetics of Rosuvastatin in Healthy Subjects Healthy Subjects | Phase 1 | 2020-09-07 |
| Completed | A Trial of Hetrombopag in Healthy Subjects Sever Aplastic Anaemia | Phase 1 | 2020-09-03 |
| Unknown | A Study to Determine the Safety, Tolerability, and Efficacy of SHR-1209 in Patients With Familial Hypercholest Familial Hypercholesterolemia | Phase 2 | 2020-09-01 |
| Completed | The Single, Multiple Dose and Food Effect Study of SHR2285 Tablets on Pharmacokinetics and Pharmacodynamics in Thrombosis | Phase 1 | 2020-08-28 |
| Completed | A Multiple Dose Study to Evaluate the Effect of SHR-1222 Injection in Postmenopausal Osteoporosis Patients Osteoporosis | Phase 1 | 2020-08-25 |
| Unknown | A Bioequivalence Study to Compare Two Formulations of SHR-1314 After Subcutaneous Injection in Healthy Subject Bioequivalence | Phase 1 | 2020-08-20 |
| Terminated | A Study of Maintenance Treatment With Fluzoparib in gBRCA/PALB2 Mutated Pancreatic Cancer Whose Disease Has No Metastatic Pancreatic Cancer | Phase 3 | 2020-08-19 |
| Completed | The Multiple Dose of PK/PD Study of SHR2285 Tablets in Healthy Subjects Thrombus | Phase 1 | 2020-08-11 |
| Withdrawn | A Trial of Famitinib in Patients With Failure of First-Line Treatment For Intrahepatic Cholangiocarcinoma Intrahepatic Cholangiocarcinoma | Phase 2 | 2020-08-10 |
| Completed | A Trial of SHR-1703 in Healthy Adults Asthma | Phase 1 | 2020-08-04 |
| Unknown | Pharmacokinetics, Pharmacodynamics and Safety of SHR4640 in Patients With Hepatic Impairment Hepatic Impairment | Phase 1 | 2020-08-04 |
| Completed | A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Rheumatoid Arthritis Rheumatoid Arthritis | Phase 3 | 2020-07-31 |
| Completed | The Pharmacokinetic(PK)/Pharmacodynamics(PD) Study of SHR7280 Tablets in Premenopausal Subjects With Endometri Endometriosis | Phase 1 / Phase 2 | 2020-07-30 |
| Unknown | A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of Or Chronic Hepatitis B | Phase 1 | 2020-07-28 |
| Completed | A Pharmacokinetic Interaction Study Between Apatinib and Rosuvastatin or Metformin in Solid Tumor Subjects. Solid Tumor, Adult | Phase 1 | 2020-07-27 |
| Completed | A Drug-drug Interaction Trial to Evaluate the Pharmacokinetics Effect of Rifampicin on Famitinib Healthy Adult Subjects | Phase 1 | 2020-07-20 |
| Completed | Safety, Tolerability, Pharmacokinetics(PK), Pharmacodynamics(PD) and Food Effect of HRS9950 in Healthy and CHB Chronic Hepatitis b | Phase 1 | 2020-07-20 |
| Completed | A Phase I Study of SHR1459 in Healthy Subjects Health, Subjective | Phase 1 | 2020-07-17 |
| Unknown | Study of Camrelizumab (SHR-1210) vs. Chemotherapy in Participants With Relapsed or Refractory Classical Hodgki Classical Hodgkin Lymphoma | Phase 3 | 2020-07-17 |
| Recruiting | A Trial of SHR-1316/Placebo in Combination With Chemotherapy in Patients With Resectable NSCLC Non-Small-Cell Lung Cancer | Phase 3 | 2020-07-14 |
| Terminated | A Phase 3 Study Comparing Carelizumab Plus Nab-paclitaxel and Apatinib, Carelizumab Plus Nab-paclitaxel, and N Breast Cancer, Triple Negative Breast Cancer | Phase 3 | 2020-07-14 |
| Unknown | A Study of Fluzoparib±Apatinib Versus Chemotherapy Treatment of Physician's Choice in HER2-negative Metastatic Treatment in HER2-negative Metastatic Breast Cancer Patients With Germline BRCA Mutation | Phase 3 | 2020-07-13 |
| Unknown | Study of Camrelizumab (SHR-1210) in Combination With Concurrent Chemoradiotherapy in Locally Advanced Esophage Esophageal Cancer | Phase 3 | 2020-06-30 |
| Completed | A Bioavailability Study of SHR1459 on Healthy Chinese Volunteers Healthy Adult Subjects | Phase 1 | 2020-06-28 |
| Completed | Effect of Rifampicin on the Pharmacokinetics of SHR6390 in Healthy Subjects Healthy Subjects | Phase 1 | 2020-06-23 |
| Completed | A Trial of SHR-1802 in Patients With Failure of Standard Treatment for Advanced Malignant Tumours Malignant Tumours | Phase 1 | 2020-06-17 |
| Completed | The DDI Study Had Been Designed to Investigate the Effect of SHR3680 on the Pharmacokinetics of Midazolam, S-W Prostate Cancer Patients | Phase 1 | 2020-06-15 |
| Unknown | Camrelizumab Combined With Apatinib Mesylate or Camrelizumab Alone for First-line Treatment in Subjects With P PD-L1 Positive Non-small Cell Lung Cancer | Phase 3 | 2020-06-15 |
| Completed | A Clinical Study of Remimazolam Tosilate in Patients Undergoing Bronchoscopy Sedation | Phase 3 | 2020-06-15 |
| Completed | A Study of Fluzoparib (SHR-3162) and Temozolomide With or Without SHR-1316 in Treating Patients With Replapsed Small Cell Lung Cancer | Phase 1 / Phase 2 | 2020-06-11 |
| Completed | Effect of Itraconazole on the Pharmacokinetics of SHR6390 in Healthy Subjects Healthy Subjects | Phase 1 | 2020-06-10 |
| Unknown | A Study to Evaluate the Pharmacokinetics of Apatinib in Subjects With Impaired Renal Function Subjects With Impaired Renal Function and Healthy Subjects | Phase 1 | 2020-06-05 |
| Completed | Study to Evaluate the Efficacy and Safety of Camrelizumab and Famitinib in Patients With Advanced Solid Tumor Solid Tumor | Phase 2 | 2020-06-05 |
| Unknown | A Study of Fluzoparib±Apatinib Versus Placebo Maintenance Treatment in Patients With Advanced Ovarian Cancer F Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma | Phase 3 | 2020-06-02 |
| Unknown | Drug-drug Interaction of SHR3680 With Repaglinide and Bupropion Prostate Cancer Patients | Phase 1 | 2020-06-01 |
| Completed | A Itraconazole Effect Study of SHR2554 on Healthy Chinese Adult Subjects Healthy Adult Subjects | Phase 1 | 2020-06-01 |
| Unknown | A Trial of Dexmedetomidine Hydrochloride Nasal Spray in Preoperative Sedation of Adults Preoperative Sedation | Phase 2 / Phase 3 | 2020-05-31 |
| Completed | A Rifampin Effect Study of SHR2554 on Healthy Chinese Adult Subjects Healthy | Phase 1 | 2020-05-28 |
| Completed | Pharmacokinetic Study of Pyrotinib and Docetaxel in Combination With Trastuzumab in Patients With HER2 Metasta Metastatic Breast Cancer | Phase 1 | 2020-05-28 |
| Completed | A Bioequivalence Study of Famitinib Malate on Healthy Chinese Volunteers Healthy Adult Subjects | Phase 1 | 2020-05-27 |
| Unknown | Drug-drug Interaction Study of Gefitinb on Apatinib in NSCLC Patients NSCLC | Phase 1 | 2020-05-26 |
| Completed | A Food Effect Study of SHR1459 on Healthy Chinese Adult Subjects Healthy Adult Subjects | Phase 1 | 2020-05-24 |
| Completed | Pharmacokinetics and Safety of SHR0302 in Patients With Hepatic Impairment Hepatic Impairment | Phase 1 | 2020-05-20 |
| Unknown | A Study of SHR0410 in Hemodialysis Patients With Pruritus Pruritus | Phase 1 | 2020-05-17 |
| Completed | A Food Effect Study of Apatinib Mesylate in Healthy Subjects Healthy Subjects | Phase 1 | 2020-05-13 |
| Completed | A Food Effect Study of FMTN on Healthy Chinese Adult Subjects Health, Subjective | Phase 1 | 2020-05-06 |
| Unknown | Apatinib and Etoposide Capsule Versus Apatinib in Patients With Platinum Resistant Ovarian Cancer Ovarian Cancer | Phase 2 | 2020-05-01 |
| Completed | A Drug-drug Interaction Trial of Loperamide Pharmacokinetics Effect on Pyrotinib Maleate Healthy Participants | Phase 1 | 2020-04-13 |
| Unknown | Study to Evaluate the Safety and Pharmacokinetics of Single-Dose Fluzoparib in Healthy Chinese Subjects Healthy Adult Male and Female Volunteers | Phase 1 | 2020-04-10 |
| Unknown | A Study to Compare Pharmacokinetic and Safety Profiles of Different Formulations of SHR-1314 After Subcutaneou Pharmacokinetic | Phase 1 | 2020-04-07 |
| Unknown | SHR-1701 in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma Nasopharyngeal Carcinoma | Phase 1 | 2020-03-27 |
| Completed | Study to Evaluate the Mass Balance and Biotransformation of [14C]SHR4640 in Chinese Healthy Adult Male Volunte Healthy Adult Male Volunteers | Phase 1 | 2020-03-19 |
| Completed | A Pharmacokinetic Interaction Study Between Apatinib Mesylate and Transporter Pgp Substrate Digoxin in Advance Advanced Solid Tumor | Phase 1 | 2020-03-12 |
| Unknown | Effect of Low-fat Diet on the Pharmacokinetics of Pyrotinib in Healthy Participants Healthy Participants | Phase 1 | 2020-03-01 |
| Completed | A Study of SHR-1501 Combined With SHR-1316 in Patients With Advanced Tumors Advanced Malignancies | Phase 1 | 2020-02-14 |
| Completed | A Study of Fluzoparib in Combination With mFOLFIRINOX in Patients With Advanced Pancreatic Cancer Advanced Pancreatic Cancer | Phase 1 / Phase 2 | 2020-01-21 |
| Completed | A Trial of Dexmedetomidine Hydrochloride Nasal Spray in Preoperative Sedation of Children Preoperative Sedation | Phase 1 | 2020-01-06 |
| Completed | Food Effect Study of DDO-3055 Tablets in Healthy Subjects Anemia in Chronic Kidney Disease | Phase 1 | 2020-01-06 |
| Unknown | A Safety and Efficacy Study of SHR4640 and Febuxostat in Subjects With Hyperuricemia Hyperuricemia | Phase 2 | 2019-12-03 |
| Suspended | A Clinical Study of SHR-1314 Injection in the Treatment of Moderate to Severe Plaque Psoriasis in Adults Plaque Psoriasis | Phase 2 | 2019-11-09 |
| Completed | Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Malignancy. Chemotherapy-Induced Thrombocytopenia | Phase 3 | 2019-11-06 |
| Completed | A Study of SHR-1501 in Patients With Advanced Tumors Advanced Malignancies | Phase 1 | 2019-10-30 |
| Completed | A Study of HR071603(Ketamine Nasal Spray) in Healthy Subjects Depression | Phase 1 | 2019-10-24 |
| Unknown | The Drug-Drug Interaction of SHR4640 and Febuxostat in Patients With Hyperuricemia Hyperuricemia | Phase 1 | 2019-10-14 |
| Unknown | A Study of Abiraterone in Combination With SHR3162 in the Treatment of mCRPC Prostate Cancer Castration-resistant Prostate Cancer | Phase 1 | 2019-09-26 |
| Active Not Recruiting | Extension Study of Hetrombopag in Severe Aplastic Anemia Treatment-naive Severe Aplastic Anemia | Phase 3 | 2019-09-19 |
| Completed | Effect of Itraconazole on the Pharmacokinetics of Pyrotinib in Healthy Subjects Healthy Subjects | Phase 1 | 2019-09-18 |
| Completed | A Study of SHR-1316 and Fluzoparib（SHR-3162） in Small Cell Lung Cancer Patients Small Cell Lung Cancer | Phase 1 | 2019-09-17 |
| Completed | Effect of Omeprazole on PK of Fluzoparib in Healthy Male Subjects Advanced Solid Tumor | Phase 1 | 2019-09-07 |
| Completed | Drug-Drug Interaction Study Between Henagliflozin Proline and Hydrochlorothiazide Diabetes in Adults | Phase 1 | 2019-08-28 |
| Unknown | Apatinib and Etoposide Capsule Versus Weekly Paclitaxel in Patients With Platinum Resistant Ovarian Cancer Ovarian Cancer | Phase 3 | 2019-08-16 |
| Completed | A Food Effect Study of SHR2554 on Healthy Chinese Male Adult Subjects Healthy Adult Subjects | Phase 1 | 2019-08-06 |
| Completed | Safety and Effect Study of SHR0532 (Drug Code) Tablets in Patients With Mild Hypertension Hypertension | Phase 1 | 2019-07-31 |
| Completed | A Study of SHR4010 in Patients With Hemodialysis Pruritus | Phase 1 | 2019-07-28 |
| Completed | A Drug-drug Interaction Trial of Rifampicin Pharmacokinetics Effect on Fluzoparib Healthy Male Subjects | Phase 1 | 2019-07-24 |
| Unknown | A Study of SHR6390 in Combination With Letrozole or Anastrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer | Phase 3 | 2019-07-19 |
| Completed | Effect of Fluconazole on PK of Fluzoparib in Healthy Male Subjects Advanced Cancer | Phase 1 | 2019-07-19 |
| Completed | A Study to Evaluate the Safety and Efficacy of DDO-3055 in Healthy Volunteers and Patients With Chronic Kidney Chronic Kidney Disease | Phase 1 | 2019-07-18 |
| Completed | A Study of Evaluating the Efficacy and Safety of SHR4640 in Subjects With Gout Gout | Phase 3 | 2019-07-16 |
| Unknown | A Study of Evaluating The Effects Of Pyrotinib After Adjuvant Trastuzumab In Women With Early Stage Breast Can Breast Cancer | Phase 3 | 2019-07-12 |
| Terminated | Phase II Study of SHR-1210(Anti-PD-1 Antibody) Combination With Apatinib Versus Pemetrexed and Carboplatin in NSCLC Stage IV, KRAS Gene Mutation, PD-1 Antibody | Phase 2 | 2019-07-11 |
| Completed | Study to Evaluate the Mass Balance and Biotransformation of [14C]-Fluzoparib in Chinese Patients With Solid Tu Solid Tumor | Phase 1 | 2019-07-08 |
| Completed | The Safety, Tolerability and Efficacy of Multiple Subcutaneous Injections of SHR-1209 in Subjects With Hyperli Hyperlipidemia | Phase 1 / Phase 2 | 2019-06-20 |
| Unknown | A Study of SHR6390 in Combination With Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Bre Advanced Breast Cancer | Phase 3 | 2019-06-13 |
| Completed | A Study to Evaluate SHR-1210 in Combination With Apatinib as First-Line Therapy in Patients With Advanced HCC Locally Advanced or Metastatic and Unresectable HCC | Phase 3 | 2019-06-10 |
| Completed | A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Apatinib and Fluzoparib in Patients With TNBC Triple Negative Breast Cancer | Phase 1 | 2019-06-04 |
| Unknown | A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With FOLFOX4 in Subjects With Advanced HCC Who Hav Advanced Hepatocellular Carcinoma | Phase 3 | 2019-05-31 |
| Completed | Metabolism and Disposition of [14C] Herombopag in Chinese Healthy Human Subjects Healthy | Phase 1 | 2019-05-25 |
| Completed | A Clinical Study of Remimazolam Tosilate Compared to Propofol for General Anesthesia During Elective Surgery Anesthesia for Elective Surgery Patients | Phase 3 | 2019-05-13 |
| Completed | Bioequivalence of Fluzoparib(SHR3162) Study on Healthy Chinese Adult Subjects Healthy Adult Subjects | Phase 1 | 2019-05-06 |
| Completed | A Trial of Maintenance Treatment With Fluzoparib Versus Placebo in Relapsed Ovarian Cancer Patients Ovarian Cancer | Phase 3 | 2019-04-30 |
| Terminated | A Study of SHR-1702 Alone or With Camrelizumab in Participants With Advanced Relapsed/Refractory Solid Tumors Advanced Solid Tumor | Phase 1 | 2019-04-28 |
| Unknown | A Study of Famitinib in Combination With HS-10296 in Patients With EGFR-mutant NSCLC EGFR-mutant Non-Small Cell Lung Cancer | Phase 2 | 2019-04-25 |
| Unknown | A Study of Pyrotinib in Combination With Trastuzumab and Docetaxel in Patients With HER2 Metastatic Breast Can Metastatic Breast Cancer | Phase 3 | 2019-04-22 |
| Completed | The PK/PD Study of A Single Subcutaneous Injection of SHR-1222 in Healthy Subjects Osteoporosis | Phase 1 | 2019-04-15 |
| Terminated | A Study of SHR3680 in Combination With SHR3162 in the Treatment of mCRPC Prostate Cancer, Castration-resistant Prostate Cancer | Phase 2 | 2019-04-08 |
| Completed | A Clinical Study To Evaluate Camrelizumab (SHR-1210) Plus Capecitabine and Oxaliplatin Followed by Sequential Gastric Cancer, GastroEsophageal Cancer | Phase 3 | 2019-03-07 |
| Completed | A Phase 2 Study to Evaluate the Efficacy and Safety of HS-20004 in Type 2 Diabetes Subjects. Diabetes Mellitus, Type 2 | Phase 2 | 2019-03-06 |
| Completed | Hetrombopag or Placebo in Treatment-Naive Severe Aplastic Anemia Severe Aplastic Anemia | Phase 3 | 2019-03-05 |
| Completed | The PK/PD Study of SHR2285 Tablets in Healthy Subjects Thrombosis | Phase 1 | 2019-02-25 |
| Completed | A Study of SHR-A1403 in Patients With Advanced Solid Tumor Advanced Solid Tumor | Phase 1 | 2019-02-13 |
| Unknown | SHR-1701 in Subjects With Metastatic or Locally Advanced Solid Tumors Solid Tumor | Phase 1 | 2019-01-24 |
| Unknown | Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors Renal Cell Carcinoma, Urothelial Carcinoma, Cervical Cancer | Phase 2 | 2019-01-23 |
| Unknown | Study of Carboplatin Plus Etoposide With or Without SHR-1316 in Participants With Untreated Extensive-Stage (E Extensive-stage Small Cell Lung Cancer | Phase 3 | 2018-12-30 |
| Completed | Study of SHR-1210 in Combination With Chemotherapy in Advanced Esophageal Cancer Advanced Esophageal Cancer | Phase 3 | 2018-12-03 |
| Terminated | A Study of SHR-1210 in Combination With BP102 in Subjects With Non-squamous NSCLC Lung Neoplasms | Phase 2 | 2018-11-30 |
| Terminated | A Study of SHR-1210 Plus Apatinib in Patients With Soft Tissue Sarcoma Sarcoma | Phase 2 | 2018-11-22 |
| Unknown | Phase I Study of SHR9146 + SHR-1210 +/- Apatinib in Patients With Advanced Solid Tumors Tumor, Solid, Cancer, Metastatic, Neoplasm Malignant | Phase 1 | 2018-11-20 |
| Terminated | A Study of SHR2554 Alone or in Combination With SHR3680 in the Treatment of mCRPC Prostate Cancer, Castration-resistant Prostate Cancer | Phase 1 / Phase 2 | 2018-11-20 |
| Unknown | SHR-1701 in Metastatic or Locally Advanced Solid Tumors Solid Tumor | Phase 1 | 2018-11-20 |
| Suspended | Safety, Tolerability and Pharmacokinetics/Pharmacodynamics (PK/PD) of SHR-1603 in Subjects With Advanced Malig Physiological Effects of Drugs, Neoplasms by Histologic Type, Lymphoma | Phase 1 | 2018-11-13 |
| Unknown | Phase III Study of Camrelizumab in Combination With Chemotherapy in Recurrent/Metastatic Nasopharyngeal Carcin Nasopharyngeal Carcinoma | Phase 3 | 2018-11-13 |
| Unknown | A Study of SHR-1210 in Combination With Carboplatin + Paclitaxel in Subjects With Squamous NSCLC Lung Cancer Squamous Cell, Lung Cancer Stage IV, PD-1 Antibody | Phase 3 | 2018-11-09 |
| Terminated | SHR-1210 in Combination With BP102 and XELOX in Patient With Metastatic Colorectal Cancer Metastatic Colorectal Cancer | Phase 2 | 2018-11-08 |
| Unknown | SHR-1316 in Combination With Chemotherapy in Patients With Esophageal Squamous Cell Cancer Advanced Esophageal Squamous Cell Cancer | Phase 2 | 2018-11-01 |
| Unknown | Safety, Tolerability and PK/PD of SHR1459 in Healthy Volunteers Healthy Volunteers | Phase 1 | 2018-09-01 |
| Completed | The PK/PD Study of A Single Subcutaneous Injection of SHR-1209 in Healthy Subjects Hypercholesteremia | Phase 1 | 2018-08-30 |
| Unknown | The PK/PD Study of SHR0532 Tablets in Healthy Subjects Hypertension | Phase 1 | 2018-08-24 |
| Completed | SHR-1210 in Recurrent/Metastatic Nasopharyngeal Carcinoma Who Have Received Previous At Least Two Lines of Che Nasopharyngeal Carcinoma | Phase 2 | 2018-08-14 |
| Active Not Recruiting | A Phase 1 Study of SHR2554 in Subjects With Relapsed or Refractory Mature Lymphoid Neoplasms Relapsed or Refractory Mature Lymphoid Neoplasms | Phase 1 | 2018-08-14 |
| Unknown | A Safety Study of Multiple Subcutaneous (s.c.) Injections of SHR-1314 in Adults With Moderate-to-severe Plaque Moderate-to-severe Plaque Psoriasis | Phase 1 | 2018-08-02 |
| Terminated | SHR9549 in ER Positive HER2 Negative Advanced Breast Cancer ER+ HER2- Advanced Breast Cancer | Phase 1 | 2018-07-25 |
| Completed | Neoadjuvant Study of Pyrotinib in Combination With Trastuzumab in Patients With HER2 Positive Breast Cancer HER2-positive Breast Cancer | Phase 3 | 2018-07-24 |
| Completed | A Study to Evaluate Different Intervals Between Dosing and Feeding on the Pharmacokinetics Immune Thrombocytopenia | Phase 1 | 2018-07-14 |
| Completed | Study of Remimazolam Tosilate in Patients Undergoing Colonoscopy Sedation | Phase 3 | 2018-06-28 |
| Completed | A Study to Evaluate the Safety and Efficacy of Hetrombopag Olamine in Severe Aplastic Anemia （SAA） Patient Severe Aplastic Anemia | Phase 1 / Phase 2 | 2018-06-20 |
| Unknown | A Study of SHR3680 in Treating Patients With Hormone Sensitive Prostate Cancer Prostate Cancer, Hormone-Dependent Prostate Cancer | Phase 3 | 2018-05-30 |
| Unknown | SHR-1210 in Patients With Relapsed or Refractory Extranodal NK/T Cell Lymphoma Extranodal NK/T-cell Lymphoma, Nasal Type | Phase 2 | 2018-05-29 |
| Completed | SHR-1210 Combined With Apatinib in Treatment of ED-SCLC After Failure of First Line Standard Therapy Small-cell Lung Cancer | Phase 2 | 2018-04-20 |
| Completed | Safety, Tolerability and PK of SHR1314 in axSpA Axial Spondyloarthritis | Phase 1 | 2018-04-19 |
| Completed | A Study of Fluzoparib（SHR-3162）in BRCA1/2-mutant Relapsed Ovarian Cancer Ovarian Cancer | Phase 1 | 2018-04-04 |
| Completed | A Study of SHR-1210 in Combination With Capecitabine + Oxaliplatin or Apatinib in Treatment of Advanced Gastri Gastric Cancer, GastroEsophageal Cancer | Phase 2 | 2018-04-02 |
| Completed | A Study of SHR6390 in Combination With Letrozole or Anastrozole or Fulvestrant in Patients With HR Positive an Advanced Breast Cancer | Phase 1 / Phase 2 | 2018-03-22 |
| Completed | A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Apatinib in Patients With Advanced HCC(RESCUE Hepatocellular Carcinoma | Phase 2 | 2018-03-08 |
| Unknown | Safety and Tolerability of SHR-1316 in Subjects With Advanced Tumors Tumor | Phase 1 | 2018-03-01 |
| Unknown | Tolerance and Pharmacokinetics of SHR1459 in Patients With Recurrent Replased/Refractory Mature B Cell Neoplas Mature B Cell Neoplasms | Phase 1 | 2018-02-06 |
| Completed | Irinotecan Liposome in Combination With 5-FU/LV Versus 5-FU/LV in Second-line Therapy for Gemcitabine-Refracto Second-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer After Treatment Failure With Gemcitabine-based Therapy | Phase 3 | 2018-01-25 |
| Completed | To Compare the Efficacy and Safety of BP102 vs. Avastin® in Combination With Paclitaxel/Carboplatin in First-l Non-small Cell Lung Cancer(NSCLC) | Phase 3 | 2018-01-25 |
| Unknown | Safety and Tolerability of HTI-1066 in Subjects With Advanced Solid Tumors Solid Tumor, Adult | Phase 1 | 2017-12-31 |
| Completed | Multi-Dose Study of SHR-1314 in Subjects With Moderate-to-severe Plaque Psoriasis Moderate-to-severe Chronic Plaque Psoriasis | Phase 1 / Phase 2 | 2017-12-15 |
| Completed | Study of SHR0302 Tablets (SHR0302) as Monotherapy in Active Rheumatoid Arthritis (RA) Patients Rheumatoid Arthritis | Phase 2 | 2017-11-24 |
| Unknown | Drug-drug Interaction Between Simvastatin and SHR3824 Type 2 Diabetes | Phase 1 | 2017-11-24 |
| Unknown | Efficacy and Safety of SHR3824 in Combination With Metformin in Subjects With Type 2 Diabetes Type 2 Diabetes Mellitus | Phase 3 | 2017-11-02 |
| Completed | Study of Remimazolam Tosilate in Patients Undergoing Diagnostic Upper GI Endoscopy Sedation | Phase 3 | 2017-09-01 |
| Unknown | A Study To Test The Effect Of Apatinib On P450 Enzymes Cytochrome P450 Interaction | Phase 1 | 2017-08-22 |
| Unknown | Safety, Pharmacokinetics and Pharmacodynamics of Intranasal Dexmedetomidine in Healthy Subjects Sedation | Phase 1 | 2017-07-26 |
| Terminated | The Study of SHR7390 in Combination With SHR-1210 and SHR3162 in Patients With Advanced Solid Tumors Solid Tumor | Phase 1 | 2017-07-24 |
| Completed | Dose-finding and Safety Study of SHR4640 in Subjects With Hyperuricemia Hyperuricemia | Phase 2 | 2017-07-20 |
| Completed | Multicentre, Randomised Phase III Study of the Efficacy and Safety of Hetrombopag Olamine in Idiopathic Thromb Idiopathic Thrombocytopenic Purpura | Phase 3 | 2017-06-30 |
| Completed | PD-1 Antibody SHR-1210 in Patients With Relapsed or Refractory Classic Hodgkin's Lymphoma Hodgkin Lymphoma, Adult | Phase 2 | 2017-06-09 |
| Unknown | Efficacy and Safety of SHR3824 as Monotherapy in Subjects With Type 2 Diabetes Type 2 Diabetes Mellitus | Phase 3 | 2017-06-01 |
| Completed | A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLC Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Respiratory Tract Neoplasms | Phase 3 | 2017-05-12 |
| Completed | Study of SHR-1210 Versus Investigator's Choice of Chemotherapy for Participants With Advanced Esophageal Cance Esophageal Carcinoma | Phase 3 | 2017-05-05 |
| Unknown | A Study to Evaluate SHR-1210 in Patients With Advanced or Metastatic NSCLC Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Respiratory Tract Neoplasms Nec | Phase 2 | 2017-05-03 |
| Unknown | Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer HER2 Positive Metastatic Breast Cancer | Phase 3 | 2017-05-03 |
| Completed | A Study to Evaluate the Safety and Efficacy of SHR-1210, Gemcitabine and Cis-platinum by R/M NPC Subjects Nasopharyngeal Carcinoma | Phase 1 | 2017-04-26 |
| Completed | A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC Advanced Primary Liver Cancer, Advanced Biliary Tract Carcinoma | Phase 2 | 2017-04-24 |
| Completed | A Study of SHR-1210 in Combination With Apatinib in Advanced Non-Small Cell Lung Cancer(NSCLC) Carcinoma, Non-Small-Cell Lung | Phase 2 | 2017-03-13 |
| Completed | A Study of Fluzoparib Given in Combination With Apatinib in Ovarian or Breast Cancer Patients Ovarian Cancer, Triple Negative Breast Cancer | Phase 1 | 2017-03-09 |
| Completed | The Drug-Drug Interaction of SHR4640, Febuxostat and Colchicine in Patients With Gout Gout | Phase 1 | 2017-02-17 |
| Unknown | A Study of Fluzoparib Given in Combination With Apatinib and Paclitaxel in Gastric Cancer Patients Recurrent and Metastatic Gastric Cancer | Phase 1 | 2017-01-01 |
| Completed | Food-Effect and Metabolism Study in Healthy Subjects Solid Tumor | Phase 1 | 2016-12-21 |
| Completed | A Study to Evaluate SHR-1210 in Subjects With Advanced HCC Hepatocellular Carcinoma Non-Resectable | Phase 2 | 2016-11-15 |
| Completed | Apatinib Dose Titration in Advanced or Metastatic Gastric Cancer Gastric Cancer | N/A | 2016-11-02 |
| Unknown | Phase I Study of SHR7390 in Patients With Advanced Solid Tumors Solid Tumor | Phase 1 | 2016-11-01 |
| Completed | A Study of Remimazolam Tosilate in Patients Undergoing Diagnostic Upper GI Endoscopy Sedation | Phase 2 | 2016-11-01 |
| Completed | A Clinica Study of Pyrotinib in Patients of Advanced Non-Small Cell Lung Cancer With HER2 Mutation Non Small Cell Lung | Phase 2 | 2016-10-20 |
| Unknown | Effect of a High-fat Meal on the Pharmacokinetics of SHR0302 and Mass Balance Study in Healthy Subjects Rheumatoid Arthritis | Phase 1 | 2016-08-01 |
| Unknown | A Study of Pyrotinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer HER2 Positive Metastatic Breast Cancer | Phase 3 | 2016-07-20 |
| Completed | Effect of Itraconazole on the Pharmacokinetics of Apatinib Neoplasms | Phase 1 | 2016-07-01 |
| Unknown | The Pharmacokinetics Study of Single and Multiple Dose of SP2086 in Healthy Volunteers Type 2 Diabetes | Phase 1 | 2016-07-01 |
| Completed | Multiple Dose Study of SHR4640 in Healthy Subjects Gout; Hyperuricemia | Phase 1 | 2016-07-01 |
| Terminated | SHR1020 Plus Docetaxel as Compared to Placebo Plus Docetaxel in 2nd Line Non Squamous Non Small Cell Lung Canc Non Squamous Non Small Cell Lung | Phase 3 | 2016-06-01 |
| Completed | A PhaseⅡ/ Ⅲ Seamless Study to Evaluate Efficacy and Safety of Paracetamol Injection as Adjuvant to Morphine-ba Post-operative Analgesia | Phase 2 / Phase 3 | 2016-06-01 |
| Completed | A Study of Irinotecan Hydrochloride Liposome in Combination With 5-FU/LV in Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2016-05-05 |
| Completed | Effect of Rifampicin on the Pharmacokinetics of Apatinib Neoplasms | Phase 1 | 2016-05-01 |
| Unknown | Multiple Doses Escalation Study of SHR0302 in Rheumatoid Arthritis (RA) Patients Rheumatoid Arthritis | Phase 1 | 2016-05-01 |
| Unknown | The Efficacy and Safety of Pregabalin Release Tablets for the Treatment of Fibromyalgia Fibromyalgia | Phase 3 | 2016-05-01 |
| Completed | A Study to Evaluate the Safety and Tolerability of Using SHR-1210 by Advanced Solid Tumor Subjects Solid Tumor, Breast Cancer, Gastrointestinal Cancer | Phase 1 | 2016-04-27 |
| Completed | A Study to Evaluate the Safety and Tolerability of Using the SHR-1210 in Patients With Advanced Melanoma Advanced Melanoma | Phase 1 | 2016-04-13 |
| Unknown | A Safety and Efficacy Study of SHR3680 in Metastatic Castration-Resistant Prostate Cancer Patients Hormone Refractory Prostate Cancer, Metastatic Prostate Carcinoma | Phase 1 / Phase 2 | 2016-04-12 |
| Completed | A Study to Evaluate the Safety and Tolerability of Using the SHR-1210 by Advanced Solid Tumor Subjects Advanced Solid Tumors | Phase 1 | 2016-04-06 |
| Unknown | The Pharmacokinetics and Pharmacodynamics Study of Single and Multiple Dose of SP2086 in Type 2 Diabetes Patie Type 2 Diabetes | Phase 1 | 2016-04-01 |
| Completed | A Study of SHR6390 in Advanced Solid Tumor Patients Neoplasm | Phase 1 | 2016-03-03 |
| Unknown | the Food Effect Pharmacokinetic, Material Balance and Metabolite Identification of SP2086 in Healthy Volunteer Type 2 Diabetes | Phase 1 | 2016-03-01 |
| Unknown | The DDI Study of SP2086 and Valsartan Type 2 Diabetes | Phase 1 | 2016-03-01 |
| Unknown | The DDI Study of SP2086 and Simvastatin Type 2 Diabetes | Phase 1 | 2016-03-01 |
| Unknown | A Tolerability and Pharmacokinetics Study of SHR6390 in Advanced Melanoma Patients Melanoma | Phase 1 | 2016-01-01 |
| Unknown | Omega-3-Acid Ethyl Esters 90 Soft Capsules for Lowering Very High Triglycerides Hypertriglyceridemia | Phase 3 | 2015-12-01 |
| Completed | The Drug-drug Interaction of SP2086 and Metformin Type 2 Diabetes | Phase 1 | 2015-12-01 |
| Completed | Single Dose Study of SHR4640 in Healthy Subjects Gout; Hyperuricemia | Phase 1 | 2015-11-01 |
| Unknown | Safety and Efficacy Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients Chronic Idiopathic Thrombocytopenic Purpura | Phase 1 | 2015-08-01 |
| Completed | The Metabolite Identification and Material Balance Study of SP2086 Type 2 Diabetes | Phase 1 | 2015-08-01 |
| Unknown | Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Patients With Hepatic Impairment Hepatic Impairment | Phase 1 | 2015-06-01 |
| Unknown | Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Type 2 Diabetes Patients With Renal Insufficient Renal Insufficiency,Type 2 Diabetes | Phase 1 | 2015-06-01 |
| Completed | A Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer Advanced Gastric or Gastroesophageal Junction Adenocarcinoma | Phase 4 | 2015-05-15 |
| Unknown | A Study of Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+Metastatic Bre HER2 Positive Metastatic Breast Cancer | Phase 1 / Phase 2 | 2015-05-01 |
| Unknown | The Drug-drug Interaction of SHR3824 and SP2086 Type 2 Diabetes | Phase 1 | 2015-05-01 |
| Unknown | First-in-Human Single Ascending Dose of SHR0302 Rheumatoid Arthritis | Phase 1 | 2015-04-01 |
| Completed | A Phase I Study of Fluzoparib in Patient With Advanced Solid Malignancies Advanced Solid Malignancies | Phase 1 | 2015-04-01 |
| Completed | A Phase 1, Randomized, Placebo-controlled, Multiple Dose Escalation Study to Investigate Safety, Pharmacokinet Type 2 Diabetic Patients | Phase 1 | 2015-03-01 |
| Unknown | Efficacy and Safety of Pregabalin Sustained Release Tablet for Postherpetic Neuralgia Postherpetic Neuralgia | Phase 3 | 2015-03-01 |